Skip to content
10-Q/A

Quarterly Report

Core Scientific, Inc./tx CORZ CORZR CORZW CORZZ

0001628280-26-013301

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 20, 2025 310.06M sh
Shares Diluted Q3 2025 · Sep 30, 2025 318.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 317.36M sh
Shares Diluted Q3 2025 · Sep 30, 2024 292.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 253.06M sh
Capex restated Q3 2025 · Sep 30, 2025 $449.75M
Capex Q3 2025 · Sep 30, 2024 $66.2M
Operating Cash Flow restated Q3 2025 · Sep 30, 2025 $120.74M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $29.09M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $453.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $836.2M
Stockholders Equity restated Q3 2025 · Sep 30, 2025 −$1.25B
Stockholders Equity restated Q3 2025 · Jun 30, 2025 −$1.19B
Stockholders Equity restated Q3 2025 · Dec 31, 2024 −$943.05M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$826.66M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$1.18B
Stockholders Equity Q3 2025 · Dec 31, 2023 −$596.94M
Current Liabilities Q3 2025 · Sep 30, 2025 $669.86M
Current Liabilities Q3 2025 · Dec 31, 2024 $134.56M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.42B
Total Liabilities Q3 2025 · Dec 31, 2024 $2.42B
Current Assets Q3 2025 · Sep 30, 2025 $1.06B
Current Assets Q3 2025 · Dec 31, 2024 $903.96M
Total Assets restated Q3 2025 · Sep 30, 2025 $2.17B
Total Assets restated Q3 2025 · Dec 31, 2024 $1.48B
Eps Diluted restated Q3 2025 · Sep 30, 2025 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.48
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.17
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$4.09
Eps Basic restated Q3 2025 · Sep 30, 2025 −$0.45
Eps Basic Q3 2025 · Sep 30, 2025 −$1.48
Eps Basic Q3 2025 · Sep 30, 2024 −$1.17
Eps Basic restated Q3 2025 · Sep 30, 2024 −$4.09
Sga Expense Q3 2025 · Sep 30, 2025 $69.35M
Sga Expense restated Q3 2025 · Sep 30, 2025 $170.85M
Sga Expense Q3 2025 · Sep 30, 2024 $40.35M
Sga Expense Q3 2025 · Sep 30, 2024 $88.66M
Net Income restated Q3 2025 · Sep 30, 2025 −$144.03M
Net Income restated Q3 2025 · Sep 30, 2025 −$504.58M
Net Income Q3 2025 · Sep 30, 2024 −$455.26M
Net Income restated Q3 2025 · Sep 30, 2024 −$1.15B
Operating Income restated Q3 2025 · Sep 30, 2025 −$54.79M
Operating Income restated Q3 2025 · Sep 30, 2025 −$128.11M
Operating Income Q3 2025 · Sep 30, 2024 −$41.22M
Operating Income restated Q3 2025 · Sep 30, 2024 −$76.67M
Gross Profit Q3 2025 · Sep 30, 2025 $3.91M
Gross Profit Q3 2025 · Sep 30, 2025 $17.14M
Gross Profit Q3 2025 · Sep 30, 2024 −$156K
Gross Profit Q3 2025 · Sep 30, 2024 $116.31M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $77.2M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $222.11M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $95.51M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $299.44M
Revenue Q3 2025 · Sep 30, 2025 $81.1M
Revenue Q3 2025 · Sep 30, 2025 $239.26M
Revenue Q3 2025 · Sep 30, 2024 $95.35M
Revenue Q3 2025 · Sep 30, 2024 $415.75M